Kim Brixen

Author PubWeight™ 97.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med 2012 3.51
2 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008 2.52
3 Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res 2013 1.78
4 Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 2009 1.76
5 Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 2008 1.51
6 Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing 2011 1.48
7 The relationship between health-related quality of life, obesity and testosterone levels in older men. Age Ageing 2013 1.47
8 Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012 1.42
9 Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 2013 1.38
10 Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 2007 1.32
11 Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) 2008 1.31
12 Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord 2002 1.27
13 Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 2006 1.24
14 Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab 2006 1.24
15 Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns 2010 1.22
16 Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab 2007 1.21
17 Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res 2009 1.16
18 Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol 2013 1.12
19 Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. J Bone Miner Res 2010 1.08
20 Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 2011 1.06
21 A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther 2003 1.06
22 Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci 2008 1.05
23 Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2008 1.00
24 Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int 2007 0.99
25 Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res 2010 0.98
26 Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur J Hum Genet 2012 0.98
27 Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int 2004 0.96
28 Bone microarchitecture and estimated strength in 499 adult Danish women and men: a cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif Tissue Int 2013 0.94
29 Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab 2007 0.94
30 Gender differences in outcome of eating disorders: a retrospective cohort study. Psychiatry Res 2010 0.94
31 Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 2012 0.93
32 Assessment of the global trigger tool to measure, monitor and evaluate patient safety in cancer patients: reliability concerns are raised. BMJ Qual Saf 2013 0.93
33 Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr) 2011 0.93
34 Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res 2008 0.92
35 Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone 2008 0.91
36 Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Curr Med Res Opin 2010 0.91
37 Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 2012 0.91
38 Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone 2013 0.90
39 MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study. Bone 2005 0.90
40 A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 2003 0.90
41 Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins. Bone 2005 0.90
42 Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone 2006 0.90
43 Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol 2008 0.90
44 Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 2005 0.89
45 The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol 2009 0.88
46 Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength. J Bone Miner Res 2014 0.88
47 Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma. Haematologica 2004 0.88
48 Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy. Br J Haematol 2003 0.88
49 Identification of rare and frequent variants of the CASR gene by high-resolution melting. Clin Chim Acta 2011 0.87
50 Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin Endocrinol (Oxf) 2009 0.87
51 Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 2002 0.87
52 Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study. BMJ 2005 0.87
53 Changes in bone mineral density (BMD) around the cemented Exeter stem: a prospective study in 18 women with 5 years follow-up. Acta Orthop 2008 0.86
54 Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 2010 0.86
55 Bone structure and estimated bone strength in obese patients evaluated by high-resolution peripheral quantitative computed tomography. Calcif Tissue Int 2014 0.86
56 A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS). Bone 2013 0.85
57 Osteoporosis and vertebral fractures in men aged 60-74 years. Age Ageing 2012 0.85
58 Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 2007 0.85
59 Handling knowledge on osteoporosis--a qualitative study. Scand J Caring Sci 2012 0.85
60 Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. J Physiol 2006 0.85
61 Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J Clin Endocrinol Metab 2002 0.85
62 Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 2002 0.84
63 Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT. J Bone Miner Res 2012 0.84
64 Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study. J Bone Miner Res 2006 0.84
65 Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study. Calcif Tissue Int 2011 0.84
66 Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 2007 0.83
67 The combination of structural parameters and areal bone mineral density improves relation to proximal femur strength: an in vitro study with high-resolution peripheral quantitative computed tomography. Calcif Tissue Int 2011 0.82
68 Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study. Clin Endocrinol (Oxf) 2002 0.82
69 Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trial. Scand J Public Health 2008 0.82
70 Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa. J Psychiatr Res 2008 0.82
71 The incidence of hip fractures in Norway -accuracy of the national Norwegian patient registry. BMC Musculoskelet Disord 2014 0.82
72 The risk-stratified osteoporosis strategy evaluation study (ROSE): a randomized prospective population-based study. Design and baseline characteristics. Calcif Tissue Int 2015 0.82
73 KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis. J Allergy Clin Immunol 2013 0.81
74 Reflections on involuntary treatment in the prevention of fatal anorexia nervosa: a review of five cases. Int J Eat Disord 2011 0.81
75 Expressing effects of osteoporosis interventions in terms of postponing of fractures. Eur J Clin Pharmacol 2002 0.81
76 Common genetic variation in the DKK1 gene is associated with hip axis length but not with bone mineral density and bone turnover markers in young adult men: results from the Odense Androgen Study. Calcif Tissue Int 2010 0.80
77 Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005. Eur J Pediatr 2008 0.80
78 Characteristics of the Danish families with multiple endocrine neoplasia type 1. Mol Cell Endocrinol 2006 0.80
79 The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study. Eur J Endocrinol 2010 0.80
80 Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels. J Am Geriatr Soc 2013 0.80
81 Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease - a population-based database study. Clin Respir J 2010 0.79
82 Bone mineral density of the femoral neck in resurfacing hip arthroplasty. Acta Orthop 2010 0.79
83 Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab 2003 0.79
84 Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets. J Bone Miner Res 2015 0.79
85 Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women. Basic Clin Pharmacol Toxicol 2005 0.78
86 Central nervous system medications and falls risk in men aged 60-75 years: the Study on Male Osteoporosis and Aging (SOMA). Age Ageing 2012 0.78
87 Birth weight and adult bone metabolism are unrelated: results from birth weight-discordant monozygotic twins. J Bone Miner Res 2013 0.78
88 Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database. J Bone Miner Res 2013 0.78
89 Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003 0.78
90 Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy. Scand J Urol 2014 0.78
91 Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT. Calcif Tissue Int 2014 0.77
92 Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy. Thromb Haemost 2007 0.77
93 Patients with eating disorders. A high-risk group for fractures. Orthop Nurs 2003 0.77
94 Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders. Clin Endocrinol (Oxf) 2009 0.77
95 Men's experiences of living with osteoporosis: focus group interviews. Am J Mens Health 2010 0.77
96 Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in Klinefelter syndrome. J Bone Miner Res 2014 0.77
97 [Treatment of osteoporosis with antiresorptive drugs]. Ugeskr Laeger 2005 0.76
98 Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution-pQCT. J Bone Miner Res 2012 0.76
99 Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts. Mol Genet Metab 2011 0.76
100 Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males. Endocrine 2013 0.76
101 Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study. Mol Biol Rep 2012 0.76
102 Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates. Scand J Public Health 2011 0.75
103 Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men. Mol Genet Metab 2012 0.75
104 Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis--a cross-sectional, longitudinal study. Biochem Med (Zagreb) 2013 0.75
105 [Improved intervention against vitamin D deficiency and osteoporosis required]. Ugeskr Laeger 2005 0.75
106 Sensitive automated ELISA for measurement of vitamin D-binding protein (Gc) in human urine. Clin Chem 2005 0.75
107 Phalangeal bone mineral density predicts incident fractures: a prospective cohort study on men and women--results from the Danish Health Examination Survey 2007–2008 (DANHES 2007–2008). Arch Osteoporos 2012 0.75
108 [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment]. Ugeskr Laeger 2005 0.75
109 Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment. Eur J Endocrinol 2011 0.75
110 [New online tool for assessment of the risk of osteoporotic fractures]. Ugeskr Laeger 2011 0.75
111 Familial hypocalciuric hypercalcemia and calcium sensing receptor. Acta Clin Croat 2014 0.75
112 Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus. Acta Derm Venereol 2016 0.75